Kalkofen Donald A. 4
4 · Protagonist Therapeutics, Inc · Filed Dec 3, 2019
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-12-03$5.10/sh+613$3,126→ 613 total - Purchase
Common Stock
2019-12-03$5.09/sh+562$2,861→ 1,175 total